TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Klaria Pharma Holding AB (publ)
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
|
3,921
|
0 |
Financial expenses |
2,542
|
5,804
|
2,499 |
Earnings before taxes |
-12,387
|
-42,538
|
-38,934 |
EBITDA |
-9,850
|
-36,735
|
-36,436 |
Total assets |
48,997
|
80,369
|
86,026 |
Current assets |
48,979
|
27,236
|
20,216 |
Current liabilities |
21,369
|
29,301
|
34,811 |
Equity capital |
27,627
|
50,839
|
50,472 |
- share capital |
1,192
|
873
|
628 |
Employees (average) |
7
|
8
|
6 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
56.4%
|
63.3%
|
58.7% |
Turnover per employee |
0
|
490
|
0 |
Profit as a percentage of turnover | -1084.9% | ||
Return on assets (ROA) |
-20.1%
|
-45.7%
|
-42.4% |
Current ratio |
229.2%
|
93.0%
|
58.1% |
Return on equity (ROE) |
-44.8%
|
-83.7%
|
-77.1% |
Change turnover |
-3,941
|
3,921
|
0 |
Change turnover % | -100% | ||
Chg. No. of employees |
-1
|
2
|
0 |
Chg. No. of employees % |
-13%
|
33%
|
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.